Sara Giulia Danielli, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhabdomyosarcoma | 3 | 2024 | 359 | 2.200 |
Why?
|
Rhabdomyosarcoma, Alveolar | 2 | 2023 | 42 | 1.080 |
Why?
|
Benzocycloheptenes | 1 | 2024 | 9 | 0.960 |
Why?
|
Immunological Synapses | 1 | 2023 | 59 | 0.850 |
Why?
|
Bacterial Infections | 1 | 2023 | 1403 | 0.480 |
Why?
|
Single-Cell Analysis | 3 | 2024 | 2380 | 0.470 |
Why?
|
Gene Expression Profiling | 5 | 2024 | 9411 | 0.360 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16939 | 0.210 |
Why?
|
Monocytes | 2 | 2024 | 2575 | 0.210 |
Why?
|
Muscle Development | 1 | 2024 | 259 | 0.210 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2022 | 100 | 0.190 |
Why?
|
Mammals | 2 | 2023 | 1131 | 0.180 |
Why?
|
Cell Differentiation | 3 | 2024 | 11481 | 0.180 |
Why?
|
I-kappa B Kinase | 1 | 2021 | 251 | 0.180 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2019 | 50 | 0.170 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13630 | 0.170 |
Why?
|
RNA Polymerase II | 1 | 2023 | 537 | 0.170 |
Why?
|
CpG Islands | 1 | 2024 | 1221 | 0.170 |
Why?
|
Interleukin-7 | 1 | 2019 | 142 | 0.160 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2018 | 44 | 0.160 |
Why?
|
Spondylitis, Ankylosing | 1 | 2019 | 152 | 0.150 |
Why?
|
Ion Channels | 1 | 2023 | 1043 | 0.150 |
Why?
|
DNA Adducts | 1 | 2018 | 94 | 0.150 |
Why?
|
Killer Cells, Natural | 2 | 2023 | 2203 | 0.140 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 1993 | 0.140 |
Why?
|
Inflammasomes | 1 | 2021 | 530 | 0.130 |
Why?
|
Prodrugs | 1 | 2018 | 259 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1596 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3584 | 0.130 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 393 | 0.130 |
Why?
|
Autoimmunity | 2 | 2022 | 1370 | 0.120 |
Why?
|
Mice | 5 | 2024 | 81208 | 0.120 |
Why?
|
Child | 4 | 2024 | 79806 | 0.100 |
Why?
|
Cell Movement | 1 | 2024 | 5206 | 0.100 |
Why?
|
Animals | 7 | 2024 | 167963 | 0.090 |
Why?
|
Cell Proliferation | 2 | 2024 | 10446 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3758 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2250 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4373 | 0.090 |
Why?
|
Autophagy | 1 | 2017 | 1337 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5253 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8515 | 0.080 |
Why?
|
DNA Damage | 1 | 2018 | 2442 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 1 | 2024 | 5643 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4925 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3763 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4550 | 0.070 |
Why?
|
Neutrophils | 1 | 2017 | 3767 | 0.060 |
Why?
|
Lipopolysaccharides | 2 | 2024 | 2209 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4642 | 0.060 |
Why?
|
Humans | 11 | 2024 | 760621 | 0.050 |
Why?
|
Phosphate-Binding Proteins | 1 | 2022 | 93 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5697 | 0.050 |
Why?
|
Chemokine CCL4 | 1 | 2020 | 126 | 0.040 |
Why?
|
Cysteine | 1 | 2023 | 895 | 0.040 |
Why?
|
Signal Transduction | 1 | 2021 | 23376 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2020 | 899 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1755 | 0.040 |
Why?
|
Synovial Fluid | 1 | 2019 | 395 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2018 | 402 | 0.040 |
Why?
|
Macrophages | 2 | 2022 | 5745 | 0.030 |
Why?
|
Adaptation, Biological | 1 | 2017 | 147 | 0.030 |
Why?
|
Myelopoiesis | 1 | 2017 | 134 | 0.030 |
Why?
|
Pyruvic Acid | 1 | 2017 | 195 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2019 | 383 | 0.030 |
Why?
|
Lipolysis | 1 | 2017 | 211 | 0.030 |
Why?
|
Immune System | 1 | 2020 | 798 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 802 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2722 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22072 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2873 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5201 | 0.020 |
Why?
|
Antibodies | 1 | 2020 | 2421 | 0.020 |
Why?
|
Fibroblasts | 1 | 2022 | 4090 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2005 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 15789 | 0.020 |
Why?
|
Protein Binding | 1 | 2023 | 9335 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2222 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2536 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2698 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4122 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8313 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4902 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4938 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1902 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6898 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15620 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2017 | 2869 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14372 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4351 | 0.020 |
Why?
|
Transcription Factors | 1 | 2023 | 12103 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22023 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12626 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7850 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10756 | 0.010 |
Why?
|
Male | 3 | 2024 | 359744 | 0.010 |
Why?
|
Female | 3 | 2024 | 391270 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54303 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29932 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17790 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 220352 | 0.010 |
Why?
|
Adult | 2 | 2024 | 219994 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41335 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 58741 | 0.010 |
Why?
|
Aged | 1 | 2024 | 169152 | 0.010 |
Why?
|